Medicinal cannabis and psychedelic manufacturer Bioxyne reported revenue of $21.3 million in the three months ending […]
The post Bioxyne ‘on track’ to hit guidance after sharp revenue growth in Q3 appeared first on Cannabiz.
Continue reading...
-
A friendly and supportive community, register today. Our forums use a separate account system.
Australia Bioxyne ‘on track’ to hit guidance after sharp revenue growth in Q3
- Thread starter Cannabiz
- Start date
Medicinal cannabis and psychedelic manufacturer Bioxyne reported revenue of $21.3 million in the three months ending […]
The post Bioxyne ‘on track’ to hit guidance after sharp revenue growth in Q3 appeared first on Cannabiz.
Continue reading...
Similar Discussions (Automatically Generated)
- Article
- Article
- Article